Zoe Saynor is an Associate Professor in Clinical Exercise Physiology and lead for both the Physical Activity, Health and Rehabilitation Thematic Research Group and the Clinical, Health and Rehabilitation Team (CHaRT) at the University of Portsmouth, UK. She is also honorary researcher at several NHS Trusts. Having competed nationally and internationally as a dual-career elite athlete (rugby union), Zoe is passionate about the application of skills and knowledge from the field of sport and exercise science and elite sport to the clinical arena. At the heart of everything she does is promoting safe and appropriate physical activity and exercise for all. She is particularly interested in the application and benefits of exercise testing and training in clinical populations and the wider concept that Exercise is Medicine. Current and previous research has spanned the lifespan, from pre-pubertal children to the elderly, and has involved working with people with the following health conditions: cystic fibrosis (CF), non-CF bronchiectasis, asthma, CF-related diabetes, type II diabetes mellitus, chronic and end-stage renal disease, arthritis, joint hypermobility, cancer, Raynaud's, inflammatory bowel disease and Coronavirus 2019 (COVID-19). She has led on global projects which aim to implement and standardise exercise testing conducted by clinical teams as well as implement physical activity and exercise training interventions that have been co-developed with key stakeholder groups.

Sandy Jack is a Professor of Prehabilitation Medicine in the Faculty of Medicine at University of Southampton, and Honorary Consultant Clinician Scientist in Perioperative Medicine at University Hospital Southampton NHS Foundation Trust. She has >20 years of experience leading and delivering healthcare services in public sectors, including community settings in the UK. She has> 15 years’ experience in prehabilitation medicine and is considered a national/international leader in her field. She was the first to show that cancer treatments decreased physical fitness, leading to poor outcomes and high–intensity exercise-training reversed/ameliorated the decline and improved tumour regression outcomes. She has a global perspective of the challenges and works with international partners to address these. Sandy is Co-Director of Fit-4-Consortium and Director of Centre for Human Integrative Physiology in the NIHR Research Facility. She is a Board member on numerous Societies. She is CI on several trials, including the NHSE&I Sustainability and Transformation Partnership Cancer Transformation funded multi-centre Wessex Fit-Cancer Surgery Trial-WesFit (http://www.wesfit.org.uk), which is evaluating multimodal prehabilitation in patients undergoing major intra-cavity cancer surgery in the community settings. In response to the pandemic, she transformed WesFit into SafeFit (http://www.SafeFit.nhs.uk) utilising virtual clinics to deliver multimodal interventions. She has co-authored over 28 publications and chief or co-investigator on >£5 million in research grants. Her team have been awarded 15 prizes including the Health Service Journal Cancer Care Initiative of the Year award for WesFit. She has recently been appointed as the theme lead for Prehabilitation for our £25 million NIHR Southampton Biomedical Research Centre.